Expert Review of Anticancer Therapy

简称 EXPERT REV ANTICANC ·ENGLAND ·出版周期 Bimonthly ·年均收录 119 篇

2.8

最新影响因子

2.20%

自引率

容易

投稿难度

偏慢,4-8周

审稿周期

期刊简介

Expert Review of Anticancer Therapy是一本专注于癌症治疗领域的国际学术期刊，ISSN号为1473-7140，由英国出版商Taylor & Francis出版，出版地为英国，出版周期为月刊。该期刊的影响因子根据最新数据在3-4之间，属于SCI收录期刊，中科院分区通常位于医学大类3区或4区，非开放获取（OA）期刊。其发文特点集中于癌症治疗的临床与转化研究，涵盖靶向治疗、免疫治疗、化疗和放疗等前沿领域，尤其注重专家综述和评论文章，旨在为临床医生和研究人员提供权威的学术参考。杂志质量较高，审稿流程严格，但作为综述类期刊，原创性研究较少，可能存在引用波动风险，适合希望了解领域动态的读者投稿或阅读。

影响因子趋势

近期发表

Regulatory and scientific challenges in paediatric oncology 2026-09-06

The primary care-oncology interface is now a patient safety frontier 2026-08-22

Access is not enough: the deliverability gap in modern oncology 2026-08-21

From fragmentation to focus: building collaborative networks for rare cancer research – the Italian TYME network as a model for care and innovation? 2026-08-24

Conversion surgery for advanced biliary tract cancer in the era of molecularly targeted therapy and immunotherapy: from unresectable disease to multidisciplinary curative strategy 2026-08-22

AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management 2026-08-15

Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing 2026-08-05

The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence 2026-07-17

The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches 2026-07-23

Overcoming therapeutic resistance in biliary tract cancer: from resistance mechanisms to dynamic precision oncology – a narrative review 2026-07-22